Wilson Sonsini Goodrich & Rosati advised Arcellx on the deal.Arcellx, a privately held clinical-stage biopharmaceutical company, announced that it raised $115 million in a Series C…
Arcellx’s $115 Million Series C Financing


Wilson Sonsini Goodrich & Rosati advised Arcellx on the deal.Arcellx, a privately held clinical-stage biopharmaceutical company, announced that it raised $115 million in a Series C…
…